Biohaven Ltd.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.1% | -23.7% | +35.1% | +2.0% | +23.4% | -8.7% | -11.9% | +58.0% | -17.7% | -8.0% | -4.5% | – | |
| – | +256.2% | +119.8% | -64.9% | -0.6% | +4.4% | +318.0% | -60.8% | +3.5% | -21.3% | +66.9% | -32.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -413.4% | – | -191.0% | – | -129.3% | – | – | -116.2% | – | – | – | – | |
| – | -62.3% | -6.4% | +570.2% | -79.3% | -92.0% | +840.8% | -49.5% | -94.4% | -38.5% | -100.0% | – | – | |
| – | -106.7% | – | -387.8% | -4.6% | -6.1% | – | -109.4% | – | -108.3% | – | +194.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -98.6% | +9,281.3% | -75.0% | +239.5% | -99.9% | +67,604.6% | -100.0% | +154,650.8% | -5.2% | -97.9% | – | |
| – | – | -151.7% | – | -378.6% | – | -99.0% | +45,007.5% | -70.8% | +129.0% | -0.2% | -182.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.